vs
Celsius Holdings, Inc.（CELH）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Celsius Holdings, Inc.的2.0倍（$1.4B vs $721.6M），瑞思迈净利率更高（27.6% vs 3.4%，领先24.2%），Celsius Holdings, Inc.同比增速更快（117.2% vs 11.0%），过去两年Celsius Holdings, Inc.的营收复合增速更高（42.4% vs 7.9%）
Celsius Holdings Inc.是美国功能饮品企业，旗下Celsius品牌主打健身饮料、能量饮品系列，产品主打健康定位，公司CEO曾表示这一差异化优势是品牌取得市场成功的核心原因。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CELH vs RMD — 直观对比
营收规模更大
RMD
是对方的2.0倍
$721.6M
营收增速更快
CELH
高出106.3%
11.0%
净利率更高
RMD
高出24.2%
3.4%
两年增速更快
CELH
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $721.6M | $1.4B |
| 净利润 | $24.7M | $392.6M |
| 毛利率 | 47.4% | 61.8% |
| 营业利润率 | 3.6% | 34.6% |
| 净利率 | 3.4% | 27.6% |
| 营收同比 | 117.2% | 11.0% |
| 净利润同比 | 231.1% | 13.9% |
| 每股收益（稀释后） | $0.04 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CELHRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $721.6M | $1.4B | ||
| Q3 25 | $725.1M | $1.3B | ||
| Q2 25 | $739.3M | $1.3B | ||
| Q1 25 | $329.3M | $1.3B | ||
| Q4 24 | $332.2M | $1.3B | ||
| Q3 24 | $265.7M | $1.2B | ||
| Q2 24 | $402.0M | $1.2B |
净利润CELHRMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | $24.7M | $392.6M | ||
| Q3 25 | $-61.0M | $348.5M | ||
| Q2 25 | $99.9M | $379.7M | ||
| Q1 25 | $44.4M | $365.0M | ||
| Q4 24 | $-18.9M | $344.6M | ||
| Q3 24 | $6.4M | $311.4M | ||
| Q2 24 | $79.8M | $292.2M |
毛利率CELHRMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | 47.4% | 61.8% | ||
| Q3 25 | 51.3% | 61.5% | ||
| Q2 25 | 51.5% | 60.8% | ||
| Q1 25 | 52.3% | 59.3% | ||
| Q4 24 | 50.2% | 58.6% | ||
| Q3 24 | 46.0% | 58.6% | ||
| Q2 24 | 52.0% | 58.5% |
营业利润率CELHRMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | 3.6% | 34.6% | ||
| Q3 25 | -11.0% | 33.4% | ||
| Q2 25 | 19.3% | 33.7% | ||
| Q1 25 | 15.8% | 33.0% | ||
| Q4 24 | -5.6% | 32.5% | ||
| Q3 24 | -1.2% | 31.6% | ||
| Q2 24 | 23.4% | 31.2% |
净利率CELHRMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | 3.4% | 27.6% | ||
| Q3 25 | -8.4% | 26.1% | ||
| Q2 25 | 13.5% | 28.2% | ||
| Q1 25 | 13.5% | 28.3% | ||
| Q4 24 | -5.7% | 26.9% | ||
| Q3 24 | 2.4% | 25.4% | ||
| Q2 24 | 19.8% | 23.9% |
每股收益（稀释后）CELHRMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | $0.04 | $2.68 | ||
| Q3 25 | $-0.27 | $2.37 | ||
| Q2 25 | $0.33 | $2.58 | ||
| Q1 25 | $0.15 | $2.48 | ||
| Q4 24 | $-0.10 | $2.34 | ||
| Q3 24 | $0.00 | $2.11 | ||
| Q2 24 | $0.28 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $398.9M | $1.4B |
| 总债务越低越好 | $676.9M | $663.8M |
| 股东权益账面价值 | $1.2B | $6.3B |
| 总资产 | $5.1B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.57× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资CELHRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $398.9M | $1.4B | ||
| Q3 25 | $806.0M | $1.4B | ||
| Q2 25 | $615.2M | $1.2B | ||
| Q1 25 | $977.3M | $932.7M | ||
| Q4 24 | $890.2M | $521.9M | ||
| Q3 24 | $903.7M | $426.4M | ||
| Q2 24 | $903.2M | $238.4M |
总债务CELHRMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | $676.9M | $403.9M | ||
| Q3 25 | $870.5M | $408.7M | ||
| Q2 25 | $871.9M | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M |
股东权益CELHRMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | $1.2B | $6.3B | ||
| Q3 25 | $1.2B | $6.1B | ||
| Q2 25 | $1.3B | $6.0B | ||
| Q1 25 | $443.1M | $5.5B | ||
| Q4 24 | $399.9M | $5.3B | ||
| Q3 24 | $423.6M | $5.2B | ||
| Q2 24 | $415.8M | $4.9B |
总资产CELHRMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | $5.1B | $8.5B | ||
| Q3 25 | $5.3B | $8.3B | ||
| Q2 25 | $3.8B | $8.2B | ||
| Q1 25 | $1.9B | $7.6B | ||
| Q4 24 | $1.8B | $7.1B | ||
| Q3 24 | $1.7B | $7.2B | ||
| Q2 24 | $1.7B | $6.9B |
负债/权益比CELHRMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | 0.57× | 0.06× | ||
| Q3 25 | 0.72× | 0.07× | ||
| Q2 25 | 0.69× | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-119.4M | — |
| 自由现金流经营现金流 - 资本支出 | $-130.0M | — |
| 自由现金流率自由现金流/营收 | -18.0% | — |
| 资本支出强度资本支出/营收 | 1.5% | — |
| 现金转化率经营现金流/净利润 | -4.83× | — |
| 过去12个月自由现金流最近4个季度 | $323.4M | — |
8季度趋势，按日历期对齐
经营现金流CELHRMD
| Q2 26 | — | — | ||
| Q4 25 | $-119.4M | $339.7M | ||
| Q3 25 | $331.8M | $457.3M | ||
| Q2 25 | $43.7M | $538.8M | ||
| Q1 25 | $103.4M | $578.7M | ||
| Q4 24 | $75.7M | $308.6M | ||
| Q3 24 | $12.9M | $325.5M | ||
| Q2 24 | $39.6M | $440.1M |
自由现金流CELHRMD
| Q2 26 | — | — | ||
| Q4 25 | $-130.0M | $311.2M | ||
| Q3 25 | $321.5M | $414.4M | ||
| Q2 25 | $35.5M | $508.2M | ||
| Q1 25 | $96.4M | $557.9M | ||
| Q4 24 | $70.3M | $288.0M | ||
| Q3 24 | $8.7M | $307.7M | ||
| Q2 24 | $30.4M | $415.2M |
自由现金流率CELHRMD
| Q2 26 | — | — | ||
| Q4 25 | -18.0% | 21.9% | ||
| Q3 25 | 44.3% | 31.0% | ||
| Q2 25 | 4.8% | 37.7% | ||
| Q1 25 | 29.3% | 43.2% | ||
| Q4 24 | 21.2% | 22.5% | ||
| Q3 24 | 3.3% | 25.1% | ||
| Q2 24 | 7.6% | 33.9% |
资本支出强度CELHRMD
| Q2 26 | — | — | ||
| Q4 25 | 1.5% | 2.0% | ||
| Q3 25 | 1.4% | 3.2% | ||
| Q2 25 | 1.1% | 2.3% | ||
| Q1 25 | 2.1% | 1.6% | ||
| Q4 24 | 1.6% | 1.6% | ||
| Q3 24 | 1.6% | 1.5% | ||
| Q2 24 | 2.3% | 2.0% |
现金转化率CELHRMD
| Q2 26 | — | — | ||
| Q4 25 | -4.83× | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | 0.44× | 1.42× | ||
| Q1 25 | 2.33× | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 2.03× | 1.05× | ||
| Q2 24 | 0.50× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
